The iCELLis® Nano Bioreactor Provides a Reliable Method to Produce Rabies Vaccines with High Titer and High Potency

- 145745
Oral
Favorite this paper
How to cite this paper?
Work Viewer
View pdf preview

Download the full PDF of this indexed paper on Galoá Proceedings — a leading platform for academic publications that connects researchers and innovative ideas worldwide. Deepen your knowledge and become part of a global scientific community.

View PDF
Institutions
  • 1 Pall Corporation
Track
  • PHARMACEUTICAL BIOTECHNOLOGY
Keywords
rabies virus
adherent cell culture
Fixed-bed bioreactor
iCELLis Nano